Chava Perry
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 29
- Chronic Lymphocytic Leukemia Research 24
-
- Lymphoma Diagnosis and Treatment 32
- Co-authors
- Yair Herishanu (57 shared papers)Hermona Soreq (13 shared papers)Irit Mazza Avivi (48 shared papers)Gabi Shefer (4 shared papers)Aaron Polliack (21 shared papers)M. Morales (4 shared papers)Erel Joffe (6 shared papers)Yotam Bronstein (7 shared papers)
- Journals
- Blood (12 papers)European Journal Of Haematology (7 papers)Annals of Hematology (7 papers)Leukemia Research (6 papers)British Journal of Haematology (5 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Chava Perry
107 papers receiving 2.7k citations
Chava Perry's Hit Papers
Peers
Comparison fields: 5 of 108
- Infectious Diseases 812
- Pathology and Forensic Medicine 539
- Genetics 254
- Oncology 446
- Biological Psychiatry 25
Countries citing papers authored by Chava Perry
This map shows the geographic impact of Chava Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chava Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chava Perry more than expected).
Fields of papers citing papers by Chava Perry
This network shows the impact of papers produced by Chava Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chava Perry. The network helps show where Chava Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Chava Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia Hit paper breakdown → | 2021 | 515 |
| 2 | 2005 | 138 | |
| 3 | 2021 | 130 | |
| 4 | 2021 | 123 | |
| 5 | 1997 | 103 | |
| 6 | 2007 | 97 | |
| 7 | 2017 | 80 | |
| 8 | 2002 | 79 | |
| 9 | 2002 | 73 | |
| 10 | 2003 | 73 | |
| 11 | 2004 | 64 | |
| 12 | 2021 | 64 | |
| 13 | 2002 | 60 | |
| 14 | 2006 | 60 | |
| 15 | 2021 | 58 | |
| 16 | 2007 | 55 | |
| 17 | 2005 | 52 | |
| 18 | 2021 | 47 | |
| 19 | 2002 | 45 | |
| 20 | 2012 | 42 |
About Chava Perry
Chava Perry is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Infectious Diseases, having authored 110 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (24 papers), CAR-T cell therapy research (11 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (7 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Infectious Diseases (812 citations), Pathology and Forensic Medicine (539 citations), Genetics (254 citations), Oncology (446 citations) and Biological Psychiatry (25 citations). Chava Perry has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Yair Herishanu, Hermona Soreq, Irit Mazza Avivi, Gabi Shefer, Aaron Polliack, M. Morales, Erel Joffe, Yotam Bronstein, Anat Aharon and Shai Levi. Their work appears in journals such as Blood, European Journal Of Haematology, Annals of Hematology, Leukemia Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.